QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

TYRA

QT59Tyra Biosciences, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
28.32
-0.75-2.58%
OverviewShort InterestFilings
TYRAQT59Tyra Biosciences, Inc.·NASDAQ
OverviewShort InterestFilings
28.32-2.58%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-
Insider Own-
Shs Outstand59.47M
Perf Week10.75%
Market Cap1.73BForward P/E-EPS next Y-2.83Insider Trans0.16%Shs Float-Perf Month-16.16%
Enterprise Value1.65BPEG0.51EPS next Q-0.67Inst Own-Short Float-Perf Quarter-25.83%
Income-126201217.00P/S0.00EPS this Y-Inst Trans-Short Ratio-Perf Half Y23.29%
Sales-P/B4.63EPS next Y-9.22%ROA-31.82%Short Interest-Perf YTD7.72%
Book/sh6.52P/C-EPS next 5Y-ROE-42.66%52W High40.65 -30.33%Perf Year195.31%
Cash/sh6.44P/FCF-EPS past 3/5Y-ROIC-36.34%52W Low8.98 215.37%Perf 3Y-
Dividend Est.-EV/EBITDA-12.63Sales past 3/5Y-Gross Margin0.00%Volatility4.41% 4.11%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM-44.37%Oper. Margin0.00%ATR (14)1.93Perf 10Y-
Dividend Ex-Date-Quick Ratio20.49Sales Y/Y TTM-Profit Margin0.00%RSI (14)42.45Recom2.00
Dividend Gr. 3/5Y-Current Ratio20.49EPS Q/Q-36.17%SMA20-3.13%Beta0.74Target Price50.50
Payout0.00%Debt/Eq0.01Sales Q/Q-SMA50-13.76%Rel Volume2.65Prev Close29.07
Employees60LT Debt/Eq0.02EarningsAug 13SMA2008.19%Avg Volume957.04KPrice28.32
IPO DateSep 15, 2021Option/ShortYes / YesEPS/Sales Surpr.-6.67% -Net Debt/EBITDA0.61Volume2,531,395Change-2.58%
Analyst Ratings
DateActionAnalystRatingTarget
Apr-14-26InitiatedGuggenheimBuy$54
Feb-17-26ReiteratedH.C. Wainwright$30 → $45
Feb-13-26ReiteratedWedbushOutperform$37 → $53
Feb-03-26ReiteratedOppenheimerOutperform$36 → $50
Jan-27-26InitiatedBarclaysOverweight$59
Jan-23-26ReiteratedPiper SandlerOverweight$42
Dec-16-25ReiteratedWedbushOutperform$37
Sep-10-25ReiteratedOppenheimerOutperform$30 → $36
Nov-11-24ReiteratedH.C. Wainwright$25 → $30
Oct-18-24ReiteratedBank of America Securities$31
Latest News
Jun-12-26
Jun-12-2608:50AM
TD Synnex To Rally More Than 8%? Here Are 10 Top Analyst Forecasts For FridayBenzinga
Jun-11-26
Jun-11-2607:49AM
Intel To Rally Around 26%? Here Are 10 Top Analyst Forecasts For ThursdayBenzinga
07:49AM
Intel To Rally Around 26%? Here Are 10 Top Analyst Forecasts For ThursdayBenzinga
Jun-10-26
Jun-10-2608:24AM
Micron Technology To $900? Here Are 10 Top Analyst Forecasts For WednesdayBenzinga
07:33AM
B of A Securities Maintains Buy on Tyra Biosciences, Raises Price Target to $42Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue
000
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A
000
Gross Profit
000
Selling, General and Administrative Excl. Other302417
Research and Development1038063
Other Operating Expense000
Operating Income-133-104-80
Interest Expense
000
Unusual Expense
———
Non-Operating Income (Expense)-13-18-11
Net Income Before Taxes-120-86-69
Income Taxes
000
Consolidated Net Income-120-86-69
Net Income From Continuing Operations-120-86-69
Net Income-120-86-69
EPS (Recurring)-2.01-1.51-1.62
EPS (Basic, Before Extraordinaries)-2.01-1.51-1.62
EPS (Diluted)-2.01-1.51-1.62
EBITDA-119-86-69
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
———
Gross Margin
———
Operating Margin
———
Net Margin
———
Shares Outstanding605743
Market Capitalization1,577——
Operating Lease Expense
———
Insider Trading Volume
$31.19$27.61$24.02$20.44$16.86● Close Price0.00M3.83M7.66M11.49M15.32MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
KAPLAN GILLADirectorMar 26 '26Option Exercise2.25106,344239,27481,403Mar 27 12:00 AM
KAPLAN GILLADirectorMar 25 '26Option Exercise2.2528,59064,32853,172Mar 27 12:00 AM
KAPLAN GILLADirectorMar 25 '26Sale36.9714,295528,50628,231Mar 27 12:00 AM
Bensen DanielChief Discovery OfficerFeb 12 '26Sale32.878,000262,965146,981Feb 13 12:00 AM
Bensen DanielChief Discovery OfficerJan 12 '26Sale28.528,000228,185154,981Jan 20 12:00 AM
MORE ROBERT JDirectorDec 19 '25Sale25.0010,000250,0003,823,425Dec 19 12:00 AM
Bensen DanielChief Discovery OfficerDec 12 '25Sale22.648,000181,159162,981Dec 16 12:00 AM
MORE ROBERT JDirectorNov 21 '25Sale20.25246,8715,000,0263,833,425Nov 25 12:00 AM
Bensen DanielChief Operating OfficerNov 19 '25Sale16.3249,956815,297170,981Nov 19 12:00 AM
Bensen DanielChief Operating OfficerNov 18 '25Sale16.0775,6331,215,627220,937Nov 19 12:00 AM
Bensen DanielChief Operating OfficerNov 17 '25Sale16.1820,072324,798296,570Nov 17 12:00 AM
Bensen DanielChief Operating OfficerNov 14 '25Sale16.02110,2281,765,489316,642Nov 17 12:00 AM
Bensen DanielChief Operating OfficerNov 13 '25Sale16.001,11117,780426,870Nov 17 12:00 AM
KAPLAN GILLADirectorJun 18 '25Sale9.789,56893,59628,231Jun 20 12:00 AM
KAPLAN GILLADirectorJun 17 '25Sale10.351010437,799Jun 20 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR